Français
ItalianoBond Bristol Myers-Squibb 3.875% ( US110122DC94 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price | 100 % ▲ |
| Country |  United States
|
| ISIN code |
 US110122DC94 ( in USD )
|
| Interest rate | 3.875% per year ( payment 2 times a year) |
| Maturity | 15/08/2025 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 368 581 000 USD |
| Cusip | 110122DC9 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers-Squibb ( United States ) , in USD, with the ISIN code US110122DC94, pays a coupon of 3.875% per year. The coupons are paid 2 times per year and the Bond maturity is 15/08/2025 The Bond issued by Bristol Myers-Squibb ( United States ) , in USD, with the ISIN code US110122DC94, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Bristol Myers-Squibb ( United States ) , in USD, with the ISIN code US110122DC94, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |